Limited data on safety in patients with advanced heart failure or severe heart disease
Supporting Satiety and Maintaining Muscle Mass Encouraging the feeling of satiety to minimize the drive to overconsume calories is a central focus for GLP-1 therapy, and can be part of a protocol alongside GLP-1 drugs or encouraged through nutrition and supplementation alone
Go Beyond Glucose Data with Nutrisense Your glucose can significantly impact how your body feels and functions
It is still important for patients taking GLP-1 medication to limit muscle wasting through exercise and high-quality protein. Losing muscle can lower metabolic rate and physical strength
Research shows that GLP-1 medications can delay this weight loss plateau compared to diet alone, but eventually, most people will hit a wall
Conclusion: This meta-analysis demonstrates that GLP-1 receptor agonists are a promising therapeutic option for patients with IIH, demonstrating significant efficacy in reducing intracranial pressure-related symptoms such as BMI, headache frequency, papilledema, and visual disturbances
